Prophylactic platelet transfusions

Current Opinion in Hematology

Volumn 17, Issue 5, 2010, Pages 411-417

  Estcourt, Lise J ^a   Stanworth, Simon J ^a   Murphy, Michael F ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

dose; platelets; prophylactic transfusion; thrombocytopenia; transfusion

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; CLINICAL TRIAL; CONCENTRATION RESPONSE; HEMATOLOGIC MALIGNANCY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME;

HEMORRHAGE; HUMANS; PLATELET COUNT; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 77955922331     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32833c07e8     Document Type: Review

References (24)

1. Kickler TS, William W. Duke: pioneer in platelet research. JAMA 2009; 301:2267-2269.
2. Blajchman MA, Slichter SJ, Heddle NM, Murphy MF. New strategies for the optimal use of platelet transfusions. Hematology (Am Soc Hematol Educ Program) 2008. pp. 198-204.
3. Slichter SJ. Controversies in platelet transfusion therapy. Annu Rev Med 1980; 31:509-540.
4. Wells AW, Llewelyn CA, Casbard A, et al. The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies. Transfus Med 2009; 19:315-328.
5. Qureshi H, Lowe D, Dobson P, et al. National comparative audit of the use of platelet transfusions in the UK. Transfusion Clinique et Biologique 2007; 14:509-513.
6. Stanworth SJ, Clarke P, Watts T, Ballard S, et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009; 124:e826-e834.
7. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985; 66: 1105-1109.
8. Tinmouth A, Tannock IF, Crump F, et al. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion 2004; 44:1711-171 9.
9. Heddle NM, Cook RJ, Tinmouth A, et al. A randomized controlled trial comparing standard and low dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood 2009; 113:1564-1573.
10. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of haemorrhage. New Engl J Med 2010; 362:600-613.
11. Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 1978; 7:523-539; Quoted in relationship between platelet count and bleeding risk. Tranfus Med Rev 2004; 18:153-167.
12. Gaydos LA, Freireich EJ, Mantel N.The quantitative relation between platelet count and hemorrhage in patients with acute leukaemia. N Engl J Med 1962; 266:905-909.
13. Stanworth SJ, Hyde C, Heddle N, et al. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation (Review). Cochrane Database Syst Rev 2004. Oct 18: CD004269.
14. British Committee for Standards in Haematology (BCSH): guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23.
15. Slichter SJ. Evidence-based platelet transfusion guidelines. Hematology (Am Soc Hematol Educ Program) 2007. pp. 172-178.
16. Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19:1519-1538.
17. BCSH guidelines. Gibson BES, Bolton-Maggs PHB, Pamphilon D, et al. Transfusion guidelines for neonates and older children. Br J Haematol 2004; 124:433-453.
18. Josephson CD, Su LL, Christensen RD, Hillyer CD, et al. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009; 123:278-285.
19. Baer VL, Lambert DK, Henry E, Christensen RD. Severe thrombocytopenia in the NICU. Pediatrics 2009; 124:e1095-e1100.
20. Gerday E, Baer VL, Lambert DK, et al. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion 2009; 49:2034-2039.
21. Friedmann AM, Sengul H, Lehmann H, et al. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 2002; 16:34-45.
22. Wandt H, Schaefer-Eckart K, Frank M, et al. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37:387-392.
23. Liumbruno G, Bennardello F, Lattanzio A, et al., Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. Recommenda tions for the transfusion of plasma and platelets. Blood Transfus 2009;7:132-150.
24. Wandt H, Schaefer-Eckart K, Pilz B, Thalheimer M, et al. Experience with a therapeutic platelet transfusion strategy in acute myeloid leukemia: preliminary results of a randomized multicenter study after enrolment of 175 patients.Blood 2009; 113:289a-290a.